Trade Summary

6 months ago, Patel Snehal, serving as CEO, CFO, 10% owner at Greenwich Lifesciences, Inc. (GLSI), purchased 4,300 shares at $21.36 per share, for a total transaction value of $91,848.00. Following this transaction, Patel Snehal now holds 5,599,402 shares of GLSI.

The trade was executed on Wednesday, December 31, 2025 and publicly disclosed via SEC Form 4 filing on Monday, January 5, 2026 at 1:06 AM ET, 5 days after the trade was made.

Greenwich Lifesciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.